|
|
Norsk
versjon
In order to register data in Cristin, you must be an academic or administrative employee.
|
|
|
|
|
|
|
|
|
Showing results 1-50 of 53
|
<< Previous
1
2
Next >>
|
2022
|
1. |
Langseth, Øystein Olstad; Myklebust, Tor Åge; Johannessen, Tom Børge; Hjertner, Øyvind; Waage, Anders. Risk of multiple myeloma and other malignancies among first- and second-degree relatives of patients with multiple myeloma: A population-based study. European Journal of Haematology 2022 ;Volume 108.(6) p. 486-492 NTNU STO HMR KREFTREG
Untitled
|
2021
|
2. |
Langseth, Øystein Olstad; Myklebust, Tor Åge; Johannessen, Tom Børge; Hjertner, Øyvind; Waage, Anders. Patterns of previous and secondary malignancies in patients with multiple myeloma. European Journal of Haematology 2021 ;Volume 106.(4) p. 529-536 NTNU STO HMR KREFTREG
Untitled
|
2020
|
3. |
Langseth, Øystein Olstad; Myklebust, Tor Åge; Johannessen, Tom Børge; Hjertner, Øyvind; Waage, Anders. Incidence and survival of multiple myeloma: a population-based study of 10 524 patients diagnosed 1982–2017. British Journal of Haematology 2020 ;Volume 191.(3) p. 418-425 NTNU STO HMR KREFTREG
Untitled
|
2018
|
4. |
Waage, Anders; Hjertner, Øyvind. Multiple myeloma and associated malignancies, a study on Norwegian registry data.. NMSG-møte september; 2018-09-06 - 2018-09-07 NTNU
Untitled
|
2015
|
5. |
Gimsing, Peter; Hjertner, Øyvind; Abildgaard, Niels; Andersen, Niels Frost; Gedde-Dahl, Tobias Jr.; Gregersen, Henrik Echternach; Klausen, Tobias Wirenfeldt; Mellqvist, Ulf-Henrik; Linder, Olle; Lindås, Roald; Tøffner Clausen, Niels Aage; Lenhoff, Stig. Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial. Bone Marrow Transplantation 2015 ;Volume 50.(10) p. 1306-1311 HAUKELAND OUS STO NTNU
Untitled
|
2013
|
6. |
Bjelland, Thor Wilhelm; Hjertner, Øyvind; Klepstad, Pål; Kaisen, Kjell; Dale, Ola; Haugen, Bjørn Olav. Clopidogrel does not work following cardiopulmonary resuscitation. European Journal of Clinical Pharmacology 2013 NTNU UIS STO
Untitled
|
|
7. |
Mellqvist, Ulf-Henrik; Gimsing, Peter; Hjertner, Øyvind; Lenhoff, Stig; Laane, Edward; Remes, Kari; Steingrimsdottir, Hlif; Abildgaard, Niels; Ahlberg, Lucia; Blimark, Cecilia; Dahl, Inger Marie; Forsberg, Karin; Gedde-Dahl, Thobias; Gregersen, Henrik; Gruber, Astrid; Gulbrandsen, Nina; Haukås, Einar; Carlson, Kristina; Kvam, Ann Kristin; Nahi, Hareth; Lindås, Roald; Andersen, Niels Frost; Turesson, Ingemar; Waage, Anders; Westin, Jan. Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial. Blood 2013 ;Volume 121.(23) p. 4647-4654 OUS NTNU STO SUS UiT HAUKELAND
Untitled
|
|
8. |
Zeinali, Fatemeh; Fossmark, Reidar; Hauso, Øyvind; Wiseth, Rune; Hjertner, Øyvind; Waldum, Helge. Serotonin in blood: Assessment of its origin by concomitant determination of beta-thromboglobulin (platelets) and chromogranin A (enterochromaffin cells). Scandinavian Journal of Clinical and Laboratory Investigation 2013 ;Volume 73.(2) p. 148-153 NTNU STO
Untitled
|
2012
|
9. |
Hjorth, Martin; Hjertner, Øyvind; Knudsen, Lene M; Gulbrandsen, Nina; Holmberg, E; Pedersen, Per Trøllund; Andersen, Niels F; Andreasson, B; Billström, R; Carlson, Kristina; Carlsson, MS; Flogegård, M; Forsberg, Karin; Gimsing, P; Karlsson, T; Linder, Olle; Nahi, Hareth; Othzen, A; Swedin, A. Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study. European Journal of Haematology 2012 ;Volume 88.(6) p. 485-496 NTNU STO OUS
Untitled
|
2010
|
10. |
Waage, Anders; Gimsing, P; Fayers, Peter; Abildgaard, N; Ahlberg, L; Bjorkstrand, B; Carlson, K; Dahl, Inger Marie; Forsberg, K; Gulbrandsen, Nina; Haukås, Einar; Hjertner, Øyvind; Hjorth, M; Karlsson, T; Knudsen, LM; Nielsen, JL; Linder, O; Mellqvist, UH; Nesthus, Ingerid; Rolke, J; Strandberg, M; Sørbø, Jon Hjalmar; Wisløff, Finn; Juliusson, G; Turesson, I. Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma. Blood 2010 ;Volume 116.(9) p. 1405-1412 NTNU UiO STO HAUKELAND SUS HNT OUS UNN
Untitled
|
|
11. |
Bjelland, Thor Wilhelm; Hjertner, Øyvind; Klepstad, Pål; Kaisen, Kjell; Dale, Ola; Haugen, Bjørn Olav. Antiplatelet effect of clopidogrel is reduced in patients treated with therapeutic hypothermia after cardiac arrest. Frampeik 2010; 2010-10-22 - 2010-10-24 NTNU SUS
Untitled
|
|
12. |
Bjelland, Thor Wilhelm; Hjertner, Øyvind; Klepstad, Pål; Kaisen, Kjell; Dale, Ola; Haugen, Bjørn Olav. Antiplatelet effect of clopidogrel is reduced in patients treated with therapeutic hypothermia after cardiac arrest. Resuscitation 2010 ;Volume 81.(12) p. 1627-1631 NTNU SUS STO
Untitled
|
|
13. |
Bjelland, Thor Wilhelm; Hjertner, Øyvind; Klepstad, Pål; Kaisen, Kjell; Dale, Ola; Haugen, Bjørn Olav. Antiplatelet effect of clopidogrel is reduced in patients treated with therapeutic hypothermia after cardiac arrest. Midt-Norsk Kardiologisk Forum; 2010-11-18 - 2010-11-19 NTNU SUS
Untitled
|
2009
|
14. |
Mellqvist, Ulf-Henrik; Westin, Jan; Gimsing, Peter; Hjertner, Øyvind; Lenhoff, Stig; Laane, Edward; Remes, Kari; Steingrimsdottir, Hlif; Abildgaard, Niels; Ahlberg, Lucia; Carlsson, Kristina; Dahl, Inger Marie S.; Forsberg, Karin; Gedde-dahl, Tobias; Gregersen, Henrik; Gruber, Astrid; Guldbrandsen, Nina; Haukås, Einar; Lindner, Olle; Nahi, Hareth; Nesthus, Ingerid; Toffner-Clausen, Nilsaage; Silvennoinen, Raija; Niels, Frost Andersen; Turesson, Ingemar; Waage, Anders. Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial. American Society of Hematology; 2009-12-05 - 2009-12-08 HAUKELAND NTNU OUS SUS UiO UNN
Untitled
|
|
15. |
Hjertner, ¯yvind. Anbefalinger om behandling av myelomatose. Årsmøte i Norsk Selskap for hematologi; 2009-03-11 - 2009-03-13 NTNU
Untitled
|
|
16. |
Hjertner, ¯yvind. Bensykdom ved myelomatose. Årsmøte i Nordisk Myelomatose Studiegruppe; 2009-11-12 - 2009-11-13 NTNU
Untitled
|
2007
|
17. |
Standal, Therese; Abildgaard, N; Fagerli, Unn-Merete; Stordal, B; Hjertner, ¯yvind; Børset, Magne; Sundan, Anders. HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma. Blood 2007 ;Volume 109.(7) p. 3024-3030 NTNU STO
Untitled
|
|
18. |
Standal, Therese; Abildgaard, Niels; Fagerli, Unn-Merete; Hjertner, ¯yvind; Størdal, Berit Fladvad; Børset, Magne; Sundan, Anders. Beinsykdommen ved myelomatose. Er HGF skurken?. Norsk Beinsymposium: Osteoporose og beinforskning i Norge; 2007-11-29 - 2007-11-29 NTNU
Untitled
|
|
19. |
Standal, Therese; Abildgaard, Niels; Fagerli, Unn-Merete; Størdal, Berit Fladvad; Hjertner, ¯yvind; Børset, Magne; Sundan, Anders. HGF:perpetrator of myeloma bone disease?. Polsk-norsk uke; 2007-10-17 - 2007-10-17 NTNU
Untitled
|
2006
|
20. |
Hjertner, ¯yvind; Standal, Therese; Børset, Magne; Sundan, Anders; Waage, Anders. Bone disease in multiple myeloma. Medical Oncology (MO) 2006 ;Volume 23.(4) p. 431-441 NTNU STO
Untitled
|
|
21. |
Standal, Therese; Abildgaard, Niels; Fagerli, Unn-merete; Størdal, Berit Fladvad; Hjertner, Øyvind; Børset, Magne; Sundan, Anders. HGF Inhibits BMP-Induced Osteoblastogenesis: Implications for the Bone Disease in Multiple Myeloma. Blood 2006 ;Volume 108. p. 3451- NTNU
Untitled
|
2005
|
22. |
Hjertner, Øyvind; Standal, Therese; Børset, Magne; Sundan, Anders; Waage, Anders. Identification of new targets for therapy of osteolytic bone disease in multiple myelomas. Current Drug Targets 2005 ;Volume 6. p. 701-711 NTNU
Untitled
|
2004
|
23. |
Holt, Randi Utne; Hjorth-Hansen, Henrik; Waage, Anders; Hjertner, ¯yvind; Sundan, Anders; Børset, Magne. Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene 2004 ;Volume 23.(17) p. 3024-3032 NTNU
Untitled
|
|
24. |
Rø, Torstein Baade; Holt, Randi Utne; Brenne, Anne Tove; Hjorth-Hansen, Henrik; Waage, Anders; Hjertner, Øyvind; Sundan, Anders; Børset, Magne. Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene 2004 ;Volume 23.(17) p. 3024-32 NTNU
Untitled
|
|
25. |
Standal, T; Hjorth-Hansen, Henrik; Rasmussen, T; Dahl, Inger Marie S.; Lenhoff, Stig; Brenne, Anne Tove; Seidel, Carina; Baykov, V; Waage, Anders; Børset, Magne; Sundan, Anders; Hjertner, ¯yvind. Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma. Haematologica 2004 ;Volume 89. p. 174-182 NTNU
Untitled
|
2003
|
26. |
Standal, Therese; Hjorth-Hansen, Henrik; Dahl, Ivar M.; Brenne, Anne Tove; Waage, Anders; Børset, Magne; Sundan, Anders; Hjertner, ¯yvind. Elevated plasma OPN in multiple myeloma patients. Multiple Myeloma 9th International Workshop; 2003-05-27 NTNU
Untitled
|
2002
|
27. |
Rø, Torstein Baade; Brenne, Anne Tove; Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Sundan, Anders; Waage, Anders; Børset, Magne. Bone morphogenetic protein-5, -6 and -7 inhibit proliferation and induce apoptosis in four human myeloma cell lines. 18th UICC International Cancer Congress; 2002-07-05 NTNU
Untitled
|
|
28. |
Rø, Torstein Baade; Holt, Randi Utne; Brenne, Anne Tove; Waage, Anders; Hjorth-Hansen, Henrik; Hjertner, ¯yvind; Sundan, Anders. Bone Morphogenetic Protein (BMP) Family Members BMP-5, BMP-6 and BMP-7 Inhibit Proliferation and Induce Apoptosis in Human Myeloma cells. American Society of Hematology Forty-fourth annual meeting; 2002-12-10 NTNU
Untitled
|
|
29. |
Standahl, Therese; Seidel, Carina; Hjertner, ¯yvind; Plesner, Torben; Sanderson, Ralph D.; Waage, Anders; Børset, Magne; Sundan, Anders. Osteoprotegerin (OPG) blir bundet, internalisert og degradert av myelomceller. Vintermøte i Norsk selskap for hematologi; 2002-03-22 NTNU
Untitled
|
|
30. |
Standal, Therese; Seidel, Carina; Hjertner, ¯yvind; Plesner, Torben; Sanderson, Ralph D.; Waage, Anders; Børset, Magne; Sundan, Anders. Osteoprotegerin is Bound, Internalized and Degraded by Multiple Myeloma Cells. Blood 2002 ;Volume 100. p. 3002-3007 NTNU
Untitled
|
|
31. |
Standal, Therese; Seidel, Carina; Hjertner, ¯yvind; Plesner, Torben; Waage, Anders; Børset, Magne; Sundan, Anders. Osteoprotegerin is bound, internalized and degraded by multiple myeloma cells. 18th UICC International Cancer Congress; 2002-07-05 NTNU
Untitled
|
|
32. |
Standal, Therese; Waage, Anders; Seidel, Carina; Hjertner, ¯yvind; Plesner, Torben; Sanderson, Ralph D.; Børset, Magne; Sundan, Anders. Increased clearance of osteoprotegerin (OPG) in multiple myeloma: OPG is internalized and degraded by myeloma cells. Nordisk forening for hematologis vårmøte; 2002-06-01 NTNU
Untitled
|
2001
|
33. |
Børset, Magne; Standahl, Therese; Hjertner, ¯yvind; Seidel, Carina; Hjorth-Hansen, Henrik; Waage, Anders; Sundan, Anders. Binding, Internalization and Degradation of Osteoprotegerin in Human Myeloma Cells. American Society of Hematology 43rd Annual Meeting and Exposition; 2001-12-11 NTNU
Untitled
|
|
34. |
Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Børset, Magne; Seidel, Carina; Waage, Anders; Sundan, Anders. Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. Blood 2001 ;Volume 97.(2) p. 516-522 NTNU
Untitled
|
|
35. |
Reseland, Janne E.; Syversen, Unni; Bakke, Ingunn; Qvigstad, G; Eide, Liv G; Hjertner, ¯yvind; Gordeladze, Jan O.; Drevon, Christian A.. Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. Journal of Bone and Mineral Research 2001 ;Volume 16. p. 1426-1433 NTNU
Untitled
|
|
36. |
Seidel, Carina; Hjertner, ¯yvind; Abildgaard, Niels; Heikendorff, Lene; Hjorth, M.; Westin, Jan; Lanng Nielsen, Johan; Hjorth-Hansen, Henrik; Waage, Anders; Sundan, Anders; Børset, Magne. Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease. Blood 2001 ;Volume 98.(7) p. 2269-2271 NTNU
Untitled
|
|
37. |
Seidel, Carina; Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Waage, Anders; Sundan, Anders; Børset, Magne; et, al.. OPG levels are reduced in patients with myeloma and correlate with skeletal involvement. Mayo Clinic: The Judith & George Goldman Symposium on Innovative Research in Myeloma; 2001-01-21 NTNU
Untitled
|
2000
|
38. |
Børset, Magne; Hjertner, ¯yvind; Yaccoby, Shmuel; Epstein, Joshua; Sanderson, Ralph D.. Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparing-binding proteins. Blood 2000 ;Volume 96. p. 2528-2536 NTNU
Untitled
|
|
39. |
Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Børset, Magne; Seidel, Carina; Waage, Anders; Sundan, Anders. Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. American Society of Hematology, Forty-sescond annual Meeting; 2000 NTNU
Untitled
|
|
40. |
Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Børset, Magne; Seidel, Carina; Waage, Anders; Sundan, Anders. Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. American Society of Hematology, Forty-second annual meeting; 2000 NTNU
Untitled
|
|
41. |
Hjertner, ¯yvind; Qvigstad, Gunnar; Hjorth-Hansen, Henrik; Seidel, Carina; Woodliff, Jeffery; Epstein, Joshua; Waage, Anders; Sundan, Anders; Børset, Magne. Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells. British Journal of Haematology 2000 ;Volume 109. p. 815-822 NTNU
Untitled
|
|
42. |
Seidel, C; Børset, M; Hjertner, ¯yvind; Cao, D; Abildgaard, N; Hjort Hansen, H; Sanderson, R; Waage, Anders; Sundan, A. Høye nivåer av løselig syndecan-1 og hepatocyttvekstfaktor (HGF) i beinmark fra myelompasienter: syndecan-1 modulerer biologisk aktivitet av HGF. Nordisk vårmøte i hematologi; 2000 NTNU
Untitled
|
|
43. |
Seidel, Carina; Børset, Magne; Hjertner, ¯yvind; Cao, Dianjun; Abildgaard, Niels; Hjorth-Hansen, Henrik; Sanderson, Ralph D; Waage, Anders; Sundan, Anders. High levels of soluble syndecan-1 in myeloma-derived bone marrow : modulation of hepatocyte growth factor activity. Blood 2000 ;Volume 96.(9) p. 3139-3146 NTNU
Untitled
|
1999
|
44. |
Hjertner, ¯yvind. Expression of urokinase plasminogen activator (uPA) and the uPA receptor (uPAR) in myeloma cells. The American Society of Hematology 41st Annual Meeting; 1999 NTNU
Untitled
|
|
45. |
Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Woodliff, J.; Waage, Anders; Børset, Magne. Expression of urokinase plasminogen activator (uPA) and the uPA receptor (uPAR) in myeloma cells. American Society of Hematology, 41st Annual Meeting,; 1999 NTNU
Untitled
|
|
46. |
Hjertner, ¯yvind; Lyngaas Torgersen, Maria; Seidel, Carina; Hjorth-Hansen, Henrik; Waage, Anders; Børset, Magne; Sundan, Anders. Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: A possible role for HGF in myeloma-associated osteolytic bone disease. Blood 1999 ;Volume 11. p. 3883-3888 NTNU
Untitled
|
|
47. |
Hjertner, ¯yvind; Torgersen, Maria Lyngaas; Seidel, Carina; Hjort-Hansen, Henrik; Waage, Anders; Børset, Magne; Sundan, Anders. Hepatocyte Growth Factor (HGF) Induces Interleukin-11 Sedretion From Osteoblasts: A Possible Role for HGF in Myeloma-Associated Osteolytic Bone Disease. Blood 1999 (11) p. 3883-3888 NTNU
Untitled
|
|
48. |
Hjorth-Hansen, Henrik; Hjertner, ¯yvind; Børset, Magne; Sundan, Anders; Waage, Anders. Hepatocyte growth factor (HGF) induces interleukin (IL)-6 production in murine osteoblasts, bone marrow stroma and whole organ cultures of calvariae. American Society of Hematology 41st Annual Meeting; 1999 NTNU
Untitled
|
|
49. |
Hjorth-Hansen, Henrik; Hjertner, ¯yvind; Seidel, Carina; Børset, Magne; Waage, Anders; Sundan, Anders. Bone morphogenetic protein (BMP)-4 induces apoptosis and inhibits proliferation in myeloma cells by inhibition of the interleukin (IL)-6 signalling pathway. American Society of Hematology 41st Annual Meeting; 1999 NTNU
Untitled
|
|
50. |
Sundan, Anders; Hjertner, ¯yvind; Torgersen, M. Lyngaas; Seidel, Carina; Hjorth-Hansen, Henrik; Waage, Anders; Børset, Magne. HGF induces IL-11 secretion from osteoblasts : a possible role for HGFin myeloma-associated bone disease. VII International Multiple Myeloma Workshop; 1999 NTNU
Untitled
|
Show next list
|